Company intelligence / Profile preview

Oxbridge Biotech Roundtable

Oxford, United Kingdom

Ownership: Private
Development stage: Other

Overview

Oxbridge Biotech Roundtable (OBR) was a non-profit organization established in 2011, serving as a platform to connect academic life sciences researchers with industry and venture capital, fostering entrepreneurship. It co-founded OneStart, a significant life sciences and healthcare startup accelerator. OBR dissolved on July 30, 2019.

Industry: Investors

Partnerships

SR One (GlaxoSmithKline corporate venture capital arm)MassBioErnest & YoungCovington & BurlingMcKinsey & CompanyImperial InnovationsRocheSV Life SciencesKymab

Beyond the preview

Go deeper on Oxbridge Biotech Roundtable.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxbridge Biotech Roundtable.

Explore the full profile